Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma - Test2 - elhamkhani - TriplyDB

Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma

Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma

http://www.wikidata.org/entity/Q35409649

about

The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy Exploring the tumor microenvironment with nanoparticles Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs High-Throughput Approaches to the Development of Molecular Imaging Agents.Bionanotechnology and the future of glioma.The use of therapeutic peptides to target and to kill cancer cells.The art of attraction: applications of multifunctional magnetic nanomaterials for malignant glioma.Uptake and metabolism of iron oxide nanoparticles in brain cells.Combinatorial peptide libraries: mining for cell-binding peptides.Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.Etchable plasmonic nanoparticle probes to image and quantify cellular internalization.Core-shell nanoparticle-based peptide therapeutics and combined hyperthermia for enhanced cancer cell apoptosis.An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.Tumor-penetrating peptides.In-fiber production of polymeric particles for biosensing and encapsulation.Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer.Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity.A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis.Tumor penetrating peptides for improved drug delivery.Tumor-targeting peptides from combinatorial libraries.Rational development of a cytotoxic peptide to trigger cell death.Targeting NF-κB in glioblastoma: A therapeutic approach De novo design of a tumor-penetrating peptide.Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages Nanoparticles coated with the tumor-penetrating peptide iRGD reduce experimental breast cancer metastasis in the brain Biotargeted nanomedicines for cancer: six tenets before you begin Targeted silver nanoparticles for ratiometric cell phenotyping.Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.pH-Selective Cytotoxicity of pHLIP-Antimicrobial Peptide Conjugates.Tumor-homing peptides as tools for targeted delivery of payloads to the placenta.Tumor-Targeted Multimodal Optical Imaging with Versatile Cadmium-Free Quantum Dots Nanotechnology-novel therapeutics for CNS disorders Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32.Dual-targeting pro-apoptotic peptide for programmed cancer cell death via specific mitochondria damage CD44v6-Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells.Peptides as targeting elements and tissue penetration devices for nanoparticles.Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.

P2860

Q26795601-3712DDF5-94F5-4766-953B-D0021D218084 Q27004205-D2F01CD5-FF48-4183-B404-2A66D310FC40 Q28082374-70D9AF16-B428-480A-9540-E5B1AC56E06E Q28647159-22092460-6988-404D-B345-DD4FEB50908C Q30275493-D741C971-6A44-4BAC-A066-CA8AB0A104D8 Q30417964-E4BE3942-0BE2-447F-8B2E-F28956BF952B Q30418414-4D3DE78C-3D59-4303-9B9D-6EF16B03E250 Q30809060-9BFA44E0-523F-45F2-B76D-5D896D708991 Q30835947-DCA0BC23-C682-4C74-9DD8-0103C4275F95 Q31144876-B131E38E-531B-48BA-8E0D-9216ABE185C7 Q33681168-8B52A78D-7B95-4E87-B0A4-CE750518E451 Q34076329-66A6B219-2AA8-4BFA-B92F-352048C34990 Q34239163-5F72ED1B-10A6-440F-AEF6-CC6F7D54917D Q34290121-42161BF6-B023-46A6-A95D-2BAF81A6CF29 Q34418330-4DC397B7-C1FA-4B4A-BE24-D7314E02D818 Q34532194-5F88B0A0-1F61-4154-9111-5BEBFDE6B45D Q34976054-674D9877-A0E7-42B9-848E-FA20F9E66E6A Q34982558-72AD9BA8-3311-4729-8A7C-7800DF54F5B7 Q35011982-68B80AEB-ECA8-45EE-B535-FF50B747EF85 Q35395576-4AE62DEB-FB71-4C8A-8937-CBE45BC192F7 Q35868066-E85B01E3-FE3C-4D92-9AF4-785E6FBD20FF Q35978545-C30C2A75-66CB-4B85-BB4F-668436404F17 Q36025723-D4CCC40B-7AB8-4576-9FBD-072998FEE377 Q36279284-55B8687E-5EE9-40BB-B1D5-9C2C683A5ABF Q36514117-1AA18BCB-C068-4983-A68F-D1669EB6DAC2 Q36544864-A8773CB9-D3B2-4078-A2C7-CE21C9CE451B Q36563662-EC530879-1BB2-4438-B879-8E395C67F8B1 Q36729317-F6009448-58A8-456B-9325-5995D3D7D093 Q36814280-8D5E24F6-298B-4736-AFBC-DBB2F4D07751 Q36849542-4797F567-0A6D-4C4C-A99E-1BF10B481F74 Q36905702-766D9A3C-F3CD-4A92-9C43-6404C831DFD9 Q37030755-CBF5CD79-42BA-46AC-9BB5-4D563EF433F0 Q37056248-6CA739C0-6BD4-44FB-9252-8B7A5AF95CB3 Q37103119-C013FFEA-E40A-40E8-8E0E-8A7560ADE5BA Q37173643-F4FDBD20-8BB3-4ED1-A57A-17122D57FB2A Q37393805-D8C7D1DA-903D-4769-8605-D809B00E8666 Q37393856-F52E0C40-0E0C-46AC-AE45-AF8EB714C0C2 Q37588008-EA58F59F-BA72-40EE-AF04-219AF29B6953 Q37627407-090E49A3-604D-4DB0-86B0-F3E637C4471D Q37682915-0D93FADD-8C43-42D7-9DDE-E93F2CF18E7F

P2860

Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma

http://www.wikidata.org/entity/Q35409649

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma

@ast

Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma

@en

type

label

Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma

@ast

Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma

@en

prefLabel

Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma

@ast

Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma

@en

P1433

Q35409649-381CA163-0F50-4BB7-9543-1A7CDABD2A61

P1476

Q35409649-2B219028-1BED-45ED-BC1D-50336515B13B

P2093

Q35409649-06E33EE1-8688-4AAF-A4C7-B48DC162C214

Q35409649-67A05590-8133-4A2F-B97E-287D7125FA1A

Q35409649-9FB0FBFC-8A51-42F3-A8B0-6558C4E30A45

Q35409649-BDB97B4F-CBE8-4243-9057-15D62FCCC973

Q35409649-C87D4AFB-F287-479C-8D5D-C2865D4A63CB

Q35409649-D728DC99-99AF-4883-BB7A-93C49D54CC40

Q35409649-F8DEFD1A-863B-4F9F-AB1F-8D88F2427A65

P2860

Q35409649-016B1EF3-7C05-474F-ADF4-D00BEF50ABAB

Q35409649-0AD1831B-A13F-40F0-8CD2-4BB9FF048FF9

Q35409649-1B89CB3C-FC70-412E-89C0-13DABF58FBCE

Q35409649-2499A074-E585-43E8-B2F8-4D1BA94C4182

Q35409649-29BC8BEE-B29E-4840-8838-3C75E32D2B5F

Q35409649-32495E3D-32C6-44EC-ABB6-C94EEAACA7DA

Q35409649-340E6F6B-F478-4166-A90F-9A5293197445

Q35409649-363CDA91-5154-4C3C-BD55-6C25ED5D9CBE

Q35409649-3F103338-8041-4B47-BE93-557B79560402

Q35409649-4AB6AE7D-3691-4D8F-83B1-243323111093

P304

Q35409649-0768EF79-5CD0-4A68-9CDF-1D981E7DBCF5

P31

Q35409649-F414F8F4-3386-41A0-8FE1-52B14314769A

P356

Q35409649-52D2238F-2F4E-42CA-98D1-D3489C569BC5

P407

Q35409649-80182B83-9F2C-4F37-8E25-BABF9F6488E7

P433

Q35409649-49D58F7A-6BA7-4199-ACCE-AAC026DF1CB0

P478

Q35409649-7DD2609D-1048-4B16-93B8-233301C8F2E4

P50

Q35409649-9B07C6E4-6E02-4737-831C-78DA1BF912CD

Q35409649-FD89F0E8-722A-46CD-AD14-FABAF3413E52

P577

Q35409649-EACFF551-FA3A-4C46-8A7B-467A24D0C2AA

P5875

Q35409649-F93FEFB4-7470-4CE5-BEBB-20AA74D47FC8

P698

Q35409649-97D699BB-AC11-4155-95FC-225FF172A1A8

P921

Q35409649-F04FC264-DC54-4CE0-B309-F42C1ED80E74

P932

Q35409649-9F29C0F4-C181-4DA4-A26F-77DE961C29F2

P356

PNAS.1114518108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma

@en

P2093

Dinorah Friedmann-Morvinski

http://www.w3.org/2001/XMLSchema#string

Inder M Verma

http://www.w3.org/2001/XMLSchema#string

Kazuki N Sugahara

http://www.w3.org/2001/XMLSchema#string

Lilach Agemy

http://www.w3.org/2001/XMLSchema#string

Olivier M Girard

http://www.w3.org/2001/XMLSchema#string

Robert F Mattrey

http://www.w3.org/2001/XMLSchema#string

Venkata Ramana Kotamraju

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting neuropilin-1 in human leukemia and lymphoma

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Malignant gliomas in adults

Drug delivery systems: entering the mainstream

Specialization of tumour vasculature.

Targeting the prostate for destruction through a vascular address.

Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma.

Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells.

Targeting of drugs and nanoparticles to tumors.

Clinical applications of angiogenic growth factors and their inhibitors.

P304

17450-17455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1114518108

http://www.w3.org/2001/XMLSchema#string

P407

P433

42

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Erkki Ruoslahti

P577

2011-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51691259

http://www.w3.org/2001/XMLSchema#string

P698

21969599

http://www.w3.org/2001/XMLSchema#string

P921

P932

3198371

http://www.w3.org/2001/XMLSchema#string